1. Home
  2. AVXL vs BHRB Comparison

AVXL vs BHRB Comparison

Compare AVXL & BHRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • BHRB
  • Stock Information
  • Founded
  • AVXL 2001
  • BHRB 1852
  • Country
  • AVXL United States
  • BHRB United States
  • Employees
  • AVXL N/A
  • BHRB N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • BHRB Major Banks
  • Sector
  • AVXL Health Care
  • BHRB Finance
  • Exchange
  • AVXL Nasdaq
  • BHRB Nasdaq
  • Market Cap
  • AVXL 779.5M
  • BHRB 847.3M
  • IPO Year
  • AVXL N/A
  • BHRB N/A
  • Fundamental
  • Price
  • AVXL $8.35
  • BHRB $62.37
  • Analyst Decision
  • AVXL Strong Buy
  • BHRB Strong Buy
  • Analyst Count
  • AVXL 2
  • BHRB 2
  • Target Price
  • AVXL $44.00
  • BHRB $76.00
  • AVG Volume (30 Days)
  • AVXL 995.5K
  • BHRB 37.5K
  • Earning Date
  • AVXL 02-12-2025
  • BHRB 01-24-2025
  • Dividend Yield
  • AVXL N/A
  • BHRB 3.48%
  • EPS Growth
  • AVXL N/A
  • BHRB N/A
  • EPS
  • AVXL N/A
  • BHRB 2.82
  • Revenue
  • AVXL N/A
  • BHRB $237,731,000.00
  • Revenue This Year
  • AVXL N/A
  • BHRB N/A
  • Revenue Next Year
  • AVXL N/A
  • BHRB $4.49
  • P/E Ratio
  • AVXL N/A
  • BHRB $22.51
  • Revenue Growth
  • AVXL N/A
  • BHRB 118.23
  • 52 Week Low
  • AVXL $3.25
  • BHRB $46.00
  • 52 Week High
  • AVXL $14.44
  • BHRB $75.32
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 40.39
  • BHRB 44.09
  • Support Level
  • AVXL $8.50
  • BHRB $62.75
  • Resistance Level
  • AVXL $9.20
  • BHRB $65.44
  • Average True Range (ATR)
  • AVXL 0.49
  • BHRB 1.63
  • MACD
  • AVXL -0.01
  • BHRB -0.12
  • Stochastic Oscillator
  • AVXL 32.23
  • BHRB 29.86

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.

About BHRB Burke & Herbert Financial Services Corp.

Burke & Herbert Financial Services Corp is the bank holding company. The bank offers a full range of business and personal financial solutions designed to meet customers' banking, borrowing, and investment needs and has over 20 branches throughout the Northern Virginia region and commercial loan offices in Fredericksburg, Loudoun County, and Richmond, Virginia, and in Bethesda, Maryland. The Company operates in one segment which includes Community Banking. The company generates revenue from sources such as Fiduciary and wealth management income, Service charges and fees on deposit accounts consist of monthly service fees, check orders, and other deposit account related fees. Debit card fees and other service charges are primarily comprised of debit and credit card income, ATM fees.

Share on Social Networks: